• 1
    Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103109.
  • 2
    Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605612.
  • 3
    Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: A report from renal allograft disease registry. Transplantation 1999; 68: 635641.
  • 4
    Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. Nephrol Dial Transplant 1999; 14: 564565.
  • 5
    Smith AC, Feehally J. New insights into the pathogenesis of IgA nephropathy. Springer Semin Immunopathol 2003; 24: 477493.
  • 6
    Berger J, Noel LH, Nabarra B. Recurrence of mesangial IgA nephropathy after renal transplantation. Contrib Nephrol 1984; 40: 195197.
  • 7
    Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309312.
  • 8
    Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993; 55: 996999.
  • 9
    Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O. The clinical course of IgA-nephropathy and Henoch—Schonlein purpura following renal transplantation. Transplantation 1986; 42: 511515.
  • 10
    Hartung R, Livingston B, Excell L, Disney A, Woodroffe AJ. Recurrence of IgA deposits/disease in grafts. An Australian Registry Survey 1980–1990. Contrib Nephrol 1995; 111: 1317.
  • 11
    Kesser M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996; 28: 99104.
  • 12
    Frohnert PP, Donadio JV, Velosa JA, Holley KE, Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997; 11: 127133.
  • 13
    Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathy after renal transplantation: A significant contributor to graft loss. Transplantation 1997; 64: 14931496.
  • 14
    Bumgardner GL, Amend WC, Ascher WL, Vincenti FG. Single centre long term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 10531060.
  • 15
    Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999; 13: 313317.
  • 16
    Kim YS, Moon JI, Jeong HJ et al. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation 2001; 71: 233238.
  • 17
    Wang AYM, Lai FM, Yu AWY et al. Recurrent IgA Nephropathy in renal transplant allografts. Am J Kidney Dis 2001; 38: 588596.
  • 18
    Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001; 60: 19481954.
  • 19
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001; 56: 279288.
  • 20
    Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003; 18: 23992404.
  • 21
    Moriyama T, Nitta K, Suzuki K et al. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 2005; 19(Suppl 14): 4148.
  • 22
    Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 2002; 13: 453460.
  • 23
    Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycohenolate mofetil. Nephrol Dial Transplant 2005; 20: 12141221.
  • 24
    Dittrich E, Schmaldienst S, Soleiman A, Hörl WH, Pohanka E. Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy. Transpl Int 2004; 17: 215220
  • 25
    Ibrahim H, Rogers T, Casingal V et al. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 2006; 81: 214219.
  • 26
    Oka K, Imai E, Moriyama T et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 2000; 15: 689695.
  • 27
    Calvino J, Lens XM, Romero R, Sanchez-Guisande D. Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 2000; 15: 8286.
  • 28
    Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, Van Ypersele de Strihou C. Course of Henoch-Schonlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation 1994; 58: 11791186.
  • 29
    Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878883.
  • 30
    Dall'Amico R, Ghiggeri G, Carraro M et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 10481055.
  • 31
    Sharma R, Sharma M, McCarthy ET, Ge XL, Savin VJ. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 2000; 58: 19731979.
  • 32
    Coward RJ, Foster RR, Patton D et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 2005; 16: 629637.
  • 33
    Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 2003; 23: 141146
  • 34
    Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003; 41: 13141321.
  • 35
    Schachter AD, Harmon WE. Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 2001; 5: 406409.
  • 36
    Baum MA, Stablein DM, Panzarino et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328333.
  • 37
    Abbott KC, Sawyers ES, Oliver JD III et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366373.
  • 38
    Stephanian E, Matas AJ, Mauer SM et al. Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation 1992; 53: 755757.
  • 39
    Ohta T, Kawaguchi H, Hattori M et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001; 71: 628633.
  • 40
    Gohh RY, Yango AF, Morrissey PE et al. Preemptive plasmapheresis and recurrence of FSGS in high risk renal transplant recipients. Am J Transplant 2005; 5: 29072912.
  • 41
    Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354: 19611963.
  • 42
    Morelon E, Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transpl Proc 2003; 35: 52S57S.
  • 43
    Höcker B, Knüppel T, Waldherr R, Schaefer F, Weber S, Tönshoff B. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporine A to sirolimus. Pediatr Nephrol 2006; DOI DOI: 10.1007/s00467-006-0148-9.
  • 44
    Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2006; 1: 109116.
  • 45
    Daniel C, Ziswiler R, Frey B et al. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative Exp Nephrol 2000; 8: 5262
  • 46
    Boardman R, Trofe J, Alloway R et al. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc 2005; 37: 817818.
  • 47
    Raafat R, Travis LB, Kalia A, Diven S. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 2000; 14: 189194
  • 48
    Hubsch H, Montane B, Abitbol C et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 2005; 20: 210216.
  • 49
    Andresdottir MB, Assmann KJ, Hoitsma AJ, Koene RA, Wetzels JF. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors, and impact on graft survival. Transplantation 1997; 63: 16281633.
  • 50
    Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 2005; 16: 22252233.
  • 51
    Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 2006; 69: 504511.
  • 52
    Josephson MA, Spargo B, Hollandsworth D, Thistlethwaite JR. The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: Case report and literature review. Am J Kidney Dis 1994; 24: 873878.
  • 53
    Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y. Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 1998; 50: 144153
  • 54
    Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 20532060.
  • 55
    Nachman PH, Segelmark M, Westman K et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int 1999; 56: 15441550.
  • 56
    Rosenstein ED, Ribot S, Ventresca E, Kramer N. Recurrence of Wegener's granulomatosis following renal transplantation. Br J Rheumatol 1994; 33: 869871.
  • 57
    Nyberg G, Akesson P, Norden G, Wieslander J. Systemic vasculitis in a kidney transplant population. Transplantation 1997; 63: 12731277
  • 58
    Lobbedez T, Comoz F, Renaudineau E et al. Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation. Am J Kidney Dis 2003; 42: E2E6.
  • 59
    Goral S, Ynares C, Shappell SB et al. Recurrent lupus nephritis in renal transplant recipients revisited: It is not rare. Transplantation 2003; 75: 651656
  • 60
    Stone JH, Millward CL, Olson JL, Amend WJ, Criswell LA. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 1998; 41: 678686
  • 61
    Moroni G, Tantardini F, Gallelli B et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 2005; 45: 903911.
  • 62
    Denton MD, Galvanek EG, Singh A, Sayegh MH. Membranous lupus nephritis in a renal allograft: Response to mycophenolate mofetil therapy. Am J Transplant 2001; 1: 288292.
  • 63
    Ahuja TS, Boughton J, Weiss V, Memon A, Remmers A Jr, Rajaraman S. Late recurrence of lupus nephritis in a renal transplant recipient: Response to mycophenolate mofetil. Am J Med Sci 2001; 322: 166169
  • 64
    Turner N, Lockwood CM, Rees AJ. Anti-glomerular basement membrane antibody mediated nephritis. In: SchrierRW, GottschalkCW, eds. Diseases of the Kidney, 5th Ed. Boston : Little, Brown & Co., 1993: 18651894.
  • 65
    Khandelwal M, McCormick BB, Lajoie G, Sweet J, Cole E, Cattran DC. Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 2004; 19: 491494.